CRISPR-Cas9 as a Trojan horse

被引：0
|
作者：
Monte, Daniel F. M. [1 ]
机构：
[1] Sao Paulo State Univ Unesp, Sch Agr & Vet Sci, BR-14884900 Jaboticabal, SP, Brazil
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 10期
关键词：
D O I：
10.1016/j.ymthe.2023.08.005
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2817 / 2818
页数：2
相关论文
共 50 条
  • [41] CRISPR-Cas9 for Drug Discovery in Oncology
    Guichard, Sylvie M.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 50: PLATFORM TECHNOLOGIES IN DRUG DISCOVERY AND VALIDATION, 2017, 50 : 61 - 85
  • [42] Energy biotechnology in the CRISPR-Cas9 era
    Estrela, Raissa
    Cate, Jamie Harrison Doudna
    CURRENT OPINION IN BIOTECHNOLOGY, 2016, 38 : 79 - 84
  • [43] CRISPR-Cas9 Checkpoint Makes the Cut
    不详
    CHEMICAL ENGINEERING PROGRESS, 2017, 113 (09) : 5 - 5
  • [44] CRISPR-Cas9 System and Its Application
    Benesova, Eva
    CHEMICKE LISTY, 2020, 114 (09): : 586 - 590
  • [45] Establishing the allosteric mechanism in CRISPR-Cas9
    Palermo, Giulia
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 145 - 146
  • [46] Target specificity of the CRISPR-Cas9 system
    Xuebing Wu
    Andrea JKriz
    Phillip ASharp
    Quantitative Biology, 2014, 2 (02) : 59 - 70
  • [47] Establishing the allosteric mechanism in CRISPR-Cas9
    Nierzwicki, Lukasz
    Arantes, Pablo Ricardo
    Saha, Aakash
    Palermo, Giulia
    WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE, 2021, 11 (03)
  • [48] Application of CRISPR-Cas9 in eye disease
    Wu, Wenyi
    Tang, Luosheng
    D'Amore, Patricia A.
    Lei, Hetian
    EXPERIMENTAL EYE RESEARCH, 2017, 161 : 116 - 123
  • [49] Modeling cancer processes with CRISPR-Cas9
    Lu, Xiao-Jie
    Qi, Xiaolong
    Zheng, Dong-Hui
    Ji, Li-Juan
    TRENDS IN BIOTECHNOLOGY, 2015, 33 (06) : 317 - 319
  • [50] CRISPR-Cas9 genome engineering revolution
    Doudna, Jennifer
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
12345